Listed

Annovis Bio, Inc.

ANVSNYSECIK 1477845HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$14.4m, Q2 FY2026
Net income−$14.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2023-11-08, accession 0001558370-23-018298. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-29, accession 0001558370-24-004393. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-08-14, accession 0001558370-24-012227. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0001558370-24-015074. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-21, accession 0001558370-25-003482. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001558370-25-011233. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001104659-25-110393. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001104659-26-097228. Derived: 6-month figure less the 3-month figure.Report this figure
Research and development$m13.8Research and development, Q3 FY2023, three months to 2023-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure8.9Research and development, Q4 FY2023, three months to 2023-12-31$8.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-21, accession 0001558370-25-003482. Derived: 12-month figure less the 9-month figure.Report this figure6.5Research and development, Q1 FY2024, three months to 2024-03-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure5.8Research and development, Q2 FY2024, three months to 2024-06-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure2.7Research and development, Q3 FY2024, three months to 2024-09-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure5.0Research and development, Q4 FY2024, three months to 2024-12-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure5.0Research and development, Q1 FY2025, three months to 2025-03-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure5.2Research and development, Q2 FY2025, three months to 2025-06-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure6.3Research and development, Q3 FY2025, three months to 2025-09-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure8.8Research and development, Q4 FY2025, three months to 2025-12-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure16.7Research and development, Q1 FY2026, three months to 2026-03-31$16.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure12.0Research and development, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Operating income$m(14.9)Operating income, Q3 FY2023, three months to 2023-09-30−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure(10.4)Operating income, Q4 FY2023, three months to 2023-12-31−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-21, accession 0001558370-25-003482. Derived: 12-month figure less the 9-month figure.Report this figure(7.8)Operating income, Q1 FY2024, three months to 2024-03-31−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure(7.8)Operating income, Q2 FY2024, three months to 2024-06-30−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure(4.4)Operating income, Q3 FY2024, three months to 2024-09-30−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(6.7)Operating income, Q4 FY2024, three months to 2024-12-31−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(6.3)Operating income, Q1 FY2025, three months to 2025-03-31−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(6.3)Operating income, Q2 FY2025, three months to 2025-06-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(7.4)Operating income, Q3 FY2025, three months to 2025-09-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(9.7)Operating income, Q4 FY2025, three months to 2025-12-31−$9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Operating income, Q1 FY2026, three months to 2026-03-31−$18.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(14.4)Operating income, Q2 FY2026, three months to 2026-06-30−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figurenot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figurenot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Net income$m(14.7)Net income, Q3 FY2023, three months to 2023-09-30−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure(22.2)Net income, Q4 FY2023, three months to 2023-12-31−$22.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-21, accession 0001558370-25-003482. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Net income, Q1 FY2024, three months to 2024-03-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(5.0)Net income, Q2 FY2024, three months to 2024-06-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(12.6)Net income, Q3 FY2024, three months to 2024-09-30−$12.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(5.9)Net income, Q4 FY2024, three months to 2024-12-31−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Net income, Q1 FY2025, three months to 2025-03-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(6.2)Net income, Q2 FY2025, three months to 2025-06-30−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(7.3)Net income, Q3 FY2025, three months to 2025-09-30−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(9.8)Net income, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Net income, Q1 FY2026, three months to 2026-03-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(14.8)Net income, Q2 FY2026, three months to 2026-06-30−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Diluted EPS$ per share(1.63)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figurenot reported(0.72)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure(0.44)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure(0.97)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figurenot reported(0.32)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(0.32)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(0.37)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figurenot reported(0.63)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(0.40)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Basic EPS$ per share(1.63)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure(0.44)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure(0.97)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figurenot reported(0.32)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(0.32)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(0.37)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figurenot reported(0.63)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(0.40)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure

Balance sheet

Cash and equivalents$18.7m, Q2 FY2026
Shareholders' equity−$4.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.4Cash and equivalents, Q3 FY2023, at 2023-09-30$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure5.8Cash and equivalents, FY2023, at 2023-12-31$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-21, accession 0001558370-25-003482.Report this figure3.1Cash and equivalents, Q1 FY2024, at 2024-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure4.0Cash and equivalents, Q2 FY2024, at 2024-06-30$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure12.6Cash and equivalents, Q3 FY2024, at 2024-09-30$12.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure10.6Cash and equivalents, FY2024, at 2024-12-31$10.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-13, accession 0001104659-26-027751.Report this figure22.2Cash and equivalents, Q1 FY2025, at 2025-03-31$22.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure17.1Cash and equivalents, Q2 FY2025, at 2025-06-30$17.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure15.3Cash and equivalents, Q3 FY2025, at 2025-09-30$15.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure19.5Cash and equivalents, FY2025, at 2025-12-31$19.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure14.2Cash and equivalents, Q1 FY2026, at 2026-03-31$14.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure18.7Cash and equivalents, Q2 FY2026, at 2026-06-30$18.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Current assets$m10.2Current assets, Q3 FY2023, at 2023-09-30$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure10.2Current assets, FY2023, at 2023-12-31$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure7.8Current assets, Q1 FY2024, at 2024-03-31$7.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Total assets$m10.2Total assets, Q3 FY2023, at 2023-09-30$10.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure10.2Total assets, FY2023, at 2023-12-31$10.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-21, accession 0001558370-25-003482.Report this figure7.8Total assets, Q1 FY2024, at 2024-03-31$7.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure5.0Total assets, Q2 FY2024, at 2024-06-30$5.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure14.4Total assets, Q3 FY2024, at 2024-09-30$14.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure13.9Total assets, FY2024, at 2024-12-31$13.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-13, accession 0001104659-26-027751.Report this figure26.7Total assets, Q1 FY2025, at 2025-03-31$26.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure21.5Total assets, Q2 FY2025, at 2025-06-30$21.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure17.2Total assets, Q3 FY2025, at 2025-09-30$17.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure21.1Total assets, FY2025, at 2025-12-31$21.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure16.2Total assets, Q1 FY2026, at 2026-03-31$16.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure22.0Total assets, Q2 FY2026, at 2026-06-30$22.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Current liabilities$m3.6Current liabilities, Q3 FY2023, at 2023-09-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure4.3Current liabilities, FY2023, at 2023-12-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-21, accession 0001558370-25-003482.Report this figure4.9Current liabilities, Q1 FY2024, at 2024-03-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure4.1Current liabilities, Q2 FY2024, at 2024-06-30$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure5.4Current liabilities, Q3 FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure3.9Current liabilities, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-13, accession 0001104659-26-027751.Report this figure2.5Current liabilities, Q1 FY2025, at 2025-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure2.8Current liabilities, Q2 FY2025, at 2025-06-30$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure3.7Current liabilities, Q3 FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure3.6Current liabilities, FY2025, at 2025-12-31$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure12.8Current liabilities, Q1 FY2026, at 2026-03-31$12.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure6.4Current liabilities, Q2 FY2026, at 2026-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Total liabilities$m3.6Total liabilities, Q3 FY2023, at 2023-09-30$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure18.0Total liabilities, FY2023, at 2023-12-31$18.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-21, accession 0001558370-25-003482.Report this figure11.2Total liabilities, Q1 FY2024, at 2024-03-31$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001558370-24-007820.Report this figure6.8Total liabilities, Q2 FY2024, at 2024-06-30$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure7.3Total liabilities, Q3 FY2024, at 2024-09-30$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure4.6Total liabilities, FY2024, at 2024-12-31$4.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-13, accession 0001104659-26-027751.Report this figure2.7Total liabilities, Q1 FY2025, at 2025-03-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure3.1Total liabilities, Q2 FY2025, at 2025-06-30$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure4.0Total liabilities, Q3 FY2025, at 2025-09-30$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure4.2Total liabilities, FY2025, at 2025-12-31$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure13.1Total liabilities, Q1 FY2026, at 2026-03-31$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure26.3Total liabilities, Q2 FY2026, at 2026-06-30$26.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure
Shareholders' equity$m6.7Shareholders' equity, Q3 FY2023, at 2023-09-30$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure(7.8)Shareholders' equity, FY2023, at 2023-12-31−$7.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-13, accession 0001104659-26-027751.Report this figure(3.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure(1.8)Shareholders' equity, Q2 FY2024, at 2024-06-30−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure7.1Shareholders' equity, Q3 FY2024, at 2024-09-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure9.3Shareholders' equity, FY2024, at 2024-12-31$9.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure24.1Shareholders' equity, Q1 FY2025, at 2025-03-31$24.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure18.3Shareholders' equity, Q2 FY2025, at 2025-06-30$18.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure13.2Shareholders' equity, Q3 FY2025, at 2025-09-30$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure16.9Shareholders' equity, FY2025, at 2025-12-31$16.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure3.1Shareholders' equity, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure(4.3)Shareholders' equity, Q2 FY2026, at 2026-06-30−$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure

Cash flow

Operating cash flow−$21.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001558370-24-015074. Derived: 9-month figure less the 6-month figure.Report this figure(9.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-21, accession 0001558370-25-003482. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure(3.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001558370-25-011233. Derived: 6-month figure less the 3-month figure.Report this figure(3.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-110393. Derived: 9-month figure less the 6-month figure.Report this figure(8.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(5.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001104659-26-097228. Derived: 6-month figure less the 3-month figure.Report this figure(3.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-110393. Derived: 9-month figure less the 6-month figure.Report this figure(8.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001104659-26-027751. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure(21.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$21.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001104659-26-097228. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)37.52m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares8.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-308,163,923 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001558370-23-018298.Report this figure9.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,951,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure9.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-308,951,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001558370-24-012227.Report this figure9.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-309,012,273 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001558370-24-015074.Report this figure10.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3110,824,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001558370-25-007584.Report this figure11.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3011,307,759 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001558370-25-011233.Report this figure13.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3012,975,808 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure17.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3117,431,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure19.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3019,486,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure19.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3019,685,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-110393.Report this figure27.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3127,847,884 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-062626.Report this figure37.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3037,518,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure

Shares outstanding: 42.61mShares outstanding, period not labelled, at 2026-08-1442,606,152 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001104659-26-097228.Report this figure at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.